South Korea vs Monaco: Prevalence of anemia among women of reproductive age
South Korea
15.7%
in 2023
Monaco
15.9%
in 2023
South Korea rank
167th
Monaco rank
166th
Prevalence of anemia among women of reproductive age over time
- South Korea
- Monaco
How they compare
Monaco currently reports 15.9% against 15.7% in South Korea, a difference of 0.2%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was South Korea ahead.
South Korea ranks 167th and Monaco ranks 166th of 192 countries.
Across the 3 decades both report, South Korea averaged higher in 2 and Monaco in 1.
Head to head by decade
| Decade | South Korea | Monaco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.3% | 12.0% | 4.3% | South Korea |
| 2010s | 13.6% | 12.8% | 0.9% | South Korea |
| 2020s | 14.9% | 15.1% | 0.1% | Monaco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, South Korea or Monaco?
- Monaco, at 15.9% against 15.7% in South Korea as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between South Korea and Monaco?
- 0.2%, with Monaco ahead.
- How many years of comparable data are there for South Korea and Monaco?
- 24 years are reported by both, from 2000 to 2023.
- How do South Korea and Monaco rank globally for prevalence of anemia among women of reproductive age?
- South Korea ranks 167th and Monaco ranks 166th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.